OrganizationsOragenics

Products 1 to 1 of 1

OG716: Lantibiotics by Oakbio + Oragenics
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (5 years ago)
Date last modified: 2019/09/12 15:16 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product